ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 30 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $7,000 | -41.7% | 12,615 | -35.8% | 0.00% | – |
Q4 2021 | $12,000 | -95.5% | 19,636 | -91.9% | 0.00% | – |
Q2 2021 | $266,000 | +109.4% | 241,991 | +300.6% | 0.00% | – |
Q1 2019 | $127,000 | +2.4% | 60,404 | +70.7% | 0.00% | – |
Q1 2018 | $124,000 | +34.8% | 35,382 | +68.8% | 0.00% | – |
Q4 2017 | $92,000 | +61.4% | 20,955 | +42.6% | 0.00% | – |
Q3 2015 | $57,000 | -50.4% | 14,694 | -46.2% | 0.00% | – |
Q2 2015 | $115,000 | +7.5% | 27,331 | +0.2% | 0.00% | – |
Q1 2015 | $107,000 | -75.3% | 27,266 | -61.1% | 0.00% | – |
Q4 2014 | $433,000 | +9.9% | 70,098 | -16.7% | 0.00% | – |
Q3 2014 | $394,000 | -3.7% | 84,162 | -1.0% | 0.00% | – |
Q2 2014 | $409,000 | -2.4% | 85,050 | +29.1% | 0.00% | – |
Q1 2014 | $419,000 | – | 65,894 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
Geduld E E | 25,000 | $160,000 | 0.08% |
PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |